COPD trials recruiting in Virginia

All COPD trials nationally

Cities in Virginia

Recruiting trials in Virginia

• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Virginia: Newport News, Norfolk, Richmond, Suffolk
• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
  NCT07082738 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · Virginia: Norfolk, Williamsburg
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
  NCT06878261 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Virginia: Williamsburg
• An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
  NCT06035120 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · Virginia: Falls Church
• Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
  NCT06891755 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 84 Years · Sex: All (male and female) · Virginia: Falls Church
• COPD Exacerbation Follow Up
  NCT07118306 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · Virginia: Falls Church
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
  NCT07190209 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Virginia: Williamsburg
• Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
  NCT07051707 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · Virginia: Richmond
• Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy
  NCT03331302 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Charlottesville
• The Effect of Interval Exercise on Functional Outcomes in Veterans With COPD and OSA
  NCT05254431 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · Virginia: Salem
• The ROAM Research Study Therapy (LTOT) Version
  NCT06810323 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Virginia: Charlottesville
• To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
  NCT07684820 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Virginia: Burke, Virginia Beach